FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313339957> ?p ?o ?g. }

• W4313339957 endingPage "493" @default.
• W4313339957 startingPage "481" @default.
• W4313339957 abstract "The vertebral column is the most common site for skeletal metastasis, often leading to debilitating pain and weakness. Metastatic cancer has unique genetic drivers that potentiate tumorigenicity. There is an unmet need for novel targeted therapy in patients with spinal metastatic disease.The authors assessed the effect of verteporfin-induced yes-associated protein (YAP) inhibition on spine metastatic cell tumorigenicity and radiation sensitivity in vitro. Animal studies used a subcutaneous xenograft mouse model to assess the use of systemic intraperitoneal verteporfin (IP-VP) and intratumoral verteporfin microparticles (IT-VP) to inhibit the tumorigenicity of lung and breast spinal metastatic tumors from primary patient-derived tissue.Verteporfin led to a dose-dependent decrease in migration, clonogenicity, and cell viability via inhibition of YAP and downstream effectors cyclin D1, CTGF, TOP2A, ANDRD1, MCL-1, FOSL2, KIF14, and KIF23. This was confirmed with knockdown of YAP. Verteporfin has an additive response when combined with radiation, and knockdown of YAP rendered cells more sensitive to radiation. The addition of verteporfin to YAP knockdown cells did not significantly alter migration, clonogenicity, or cell viability. IP-VP and IT-VP led to diminished tumor growth (p < 0.0001), especially when combined with radiation (p < 0.0001). Tissue analysis revealed diminished expression of YAP (p < 0.0001), MCL-1 (p < 0.0001), and Ki-67 (p < 0.0001) in tissue from verteporfin-treated tumors compared with vehicle-treated tumors.This is the first study to demonstrate that verteporfin-mediated inhibition of YAP leads to diminished tumorigenicity in lung and breast spinal metastatic cancer cells. Targeting of YAP with verteporfin offers promising results that could be translated to human clinical trials." @default.
• W4313339957 created "2023-01-06" @default.
• W4313339957 creator A5000491993 @default.
• W4313339957 creator A5001876568 @default.
• W4313339957 creator A5003451952 @default.
• W4313339957 creator A5004166321 @default.
• W4313339957 creator A5029294194 @default.
• W4313339957 creator A5030990250 @default.
• W4313339957 creator A5035220125 @default.
• W4313339957 creator A5037693618 @default.
• W4313339957 creator A5048557100 @default.
• W4313339957 creator A5057649214 @default.
• W4313339957 creator A5069696402 @default.
• W4313339957 creator A5074588897 @default.
• W4313339957 date "2023-04-01" @default.
• W4313339957 modified "2023-09-25" @default.
• W4313339957 title "Verteporfin-loaded microparticles for radiosensitization of preclinical lung and breast metastatic spine cancer" @default.
• W4313339957 cites W1521856066 @default.
• W4313339957 cites W1555734794 @default.
• W4313339957 cites W1965658365 @default.
• W4313339957 cites W2002363917 @default.
• W4313339957 cites W2066155004 @default.
• W4313339957 cites W2068571703 @default.
• W4313339957 cites W2104302044 @default.
• W4313339957 cites W2111750969 @default.
• W4313339957 cites W2135726634 @default.
• W4313339957 cites W2149327445 @default.
• W4313339957 cites W2159587614 @default.
• W4313339957 cites W2165200432 @default.
• W4313339957 cites W2201931409 @default.
• W4313339957 cites W2287163002 @default.
• W4313339957 cites W2306059038 @default.
• W4313339957 cites W2323479061 @default.
• W4313339957 cites W2324850257 @default.
• W4313339957 cites W2346608779 @default.
• W4313339957 cites W2403658758 @default.
• W4313339957 cites W2515734953 @default.
• W4313339957 cites W2555771555 @default.
• W4313339957 cites W2561879836 @default.
• W4313339957 cites W2605114885 @default.
• W4313339957 cites W2606348384 @default.
• W4313339957 cites W2620042166 @default.
• W4313339957 cites W2763732767 @default.
• W4313339957 cites W2810967230 @default.
• W4313339957 cites W2885291746 @default.
• W4313339957 cites W2895725626 @default.
• W4313339957 cites W2898785047 @default.
• W4313339957 cites W2904073422 @default.
• W4313339957 cites W2916055874 @default.
• W4313339957 cites W2940889523 @default.
• W4313339957 cites W2970147023 @default.
• W4313339957 cites W2973157401 @default.
• W4313339957 cites W2995215192 @default.
• W4313339957 cites W3012749684 @default.
• W4313339957 cites W3093397370 @default.
• W4313339957 cites W3093568517 @default.
• W4313339957 cites W4206142021 @default.
• W4313339957 cites W2079483576 @default.
• W4313339957 doi "https://doi.org/10.3171/2022.11.spine22867" @default.
• W4313339957 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36585863" @default.
• W4313339957 hasPublicationYear "2023" @default.
• W4313339957 type Work @default.
• W4313339957 citedByCount "0" @default.
• W4313339957 crossrefType "journal-article" @default.
• W4313339957 hasAuthorship W4313339957A5000491993 @default.
• W4313339957 hasAuthorship W4313339957A5001876568 @default.
• W4313339957 hasAuthorship W4313339957A5003451952 @default.
• W4313339957 hasAuthorship W4313339957A5004166321 @default.
• W4313339957 hasAuthorship W4313339957A5029294194 @default.
• W4313339957 hasAuthorship W4313339957A5030990250 @default.
• W4313339957 hasAuthorship W4313339957A5035220125 @default.
• W4313339957 hasAuthorship W4313339957A5037693618 @default.
• W4313339957 hasAuthorship W4313339957A5048557100 @default.
• W4313339957 hasAuthorship W4313339957A5057649214 @default.
• W4313339957 hasAuthorship W4313339957A5069696402 @default.
• W4313339957 hasAuthorship W4313339957A5074588897 @default.
• W4313339957 hasConcept C118487528 @default.
• W4313339957 hasConcept C121608353 @default.
• W4313339957 hasConcept C126322002 @default.
• W4313339957 hasConcept C142724271 @default.
• W4313339957 hasConcept C143998085 @default.
• W4313339957 hasConcept C173396325 @default.
• W4313339957 hasConcept C2775930923 @default.
• W4313339957 hasConcept C2776403814 @default.
• W4313339957 hasConcept C2779013556 @default.
• W4313339957 hasConcept C2781148688 @default.
• W4313339957 hasConcept C2781359195 @default.
• W4313339957 hasConcept C502942594 @default.
• W4313339957 hasConcept C530470458 @default.
• W4313339957 hasConcept C54355233 @default.
• W4313339957 hasConcept C71924100 @default.
• W4313339957 hasConcept C81885089 @default.
• W4313339957 hasConcept C86803240 @default.
• W4313339957 hasConceptScore W4313339957C118487528 @default.
• W4313339957 hasConceptScore W4313339957C121608353 @default.
• W4313339957 hasConceptScore W4313339957C126322002 @default.
• W4313339957 hasConceptScore W4313339957C142724271 @default.
• W4313339957 hasConceptScore W4313339957C143998085 @default.

• next